Phoenix Biotech Acquisition Corp. (PBAX) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Phoenix Biotech Acquisition Corp. (PBAX:NASDAQ), powered by AI.
- Current Price
- $0.01
- P/E Ratio
- -0.4
- Market Cap
- 269,912
- Sector
- Financial Services
What is the Phoenix Biotech Acquisition Corp. stock price forecast?
Phoenix Biotech Acquisition Corp. is currently trading at $0.01. View real-time AI analysis on Alpha Lenz.
What is Phoenix Biotech Acquisition Corp. insider trading activity?
View the latest insider trading data for Phoenix Biotech Acquisition Corp. on Alpha Lenz.
What is Phoenix Biotech Acquisition Corp.'s P/E ratio?
Phoenix Biotech Acquisition Corp.'s P/E ratio is -0.4.
Phoenix Biotech Acquisition Corp.
NASDAQ · PBAX“Phoenix Biotech Acquisition Corp. trades at a P/E of -0.4 (undervalued) with modest ROE of -0.8%.”
Ask for details →Company Overview
Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. Phoenix Biotech Acquisition Corp. was incorporated in 2021 and is based in Oakland, California.
Company Statistics
FY 2022Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“Phoenix Biotech Acquisition Corp. trades at a P/E of -0.4 (undervalued) with modest ROE of -0.8%.”
Ask for details →Frequently Asked Questions
Phoenix Biotech Acquisition Corp. (ticker: PBAX) is a company listed on NASDAQ in the Financial Services sector (Shell Companies). Market cap is $269,912.
The current price is $0.012 with a P/E ratio of -0.4x and P/B of 0.11x.
ROE is -0.77%.